Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $957.78 ($96K) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($96k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $957.78 | 2 | $2K | 2.0% |
| 2 | $958.86 | 2 | $2K | 2.0% |
| 3 | $959.47 | 9 | $9K | 9.0% |
| 4 | $960.53 | 15 | $14K | 15.0% |
| 5 | $961.59 | 14 | $13K | 14.0% |
| 6 | $962.42 | 9 |
| $9K |
| 9.0% |
| 7 | $963.60 | 20 | $19K | 20.0% |
| 8 | $964.45 | 16 | $15K | 16.0% |
| 9 | $965.35 | 13 | $13K | 13.0% |
| Total | $962.53 avg | 100 | $96K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |